Tinnitus affects over 25 million adults in the U.S., posing significant challenges in managing its distressing symptoms. Although diverse factors contribute to its onset, including hearing loss and exposure to loud noise, effective treatments have remained elusive. However, a novel option recently approved by the FDA offers hope – a device utilizing electrical stimulation of the tongue.
Victoria Banks, a singer-songwriter in Nashville, Tennessee, experienced debilitating tinnitus until she discovered the device, known as Lenire. Its innovative approach, involving tongue stimulation and audio therapy, yielded promising results. A clinical trial found that 84% of participants experienced significant symptom reduction, prompting Brian Fligor, an audiologist, to adopt it for his patients.
Lenire’s mechanism involves redirecting the brain’s attention away from the tinnitus buzz, akin to shifting a spotlight’s focus. This alleviates the distress associated with tinnitus, making it less intrusive. Victoria Banks attests to its effectiveness, noting a remarkable reduction in her symptoms and a renewed ability to engage in music-related activities.
Despite its benefits, the device comes with a hefty price tag, often not covered by insurance. However, its efficacy has garnered support, with over 80% of participants recommending it to others. Yet, questions linger regarding its long-term durability and cost-effectiveness.
For individuals like Bruce Freeman, combining Lenire with hearing aids has proven beneficial in managing tinnitus. Freeman emphasizes the importance of mindfulness practices, such as swimming, in alleviating symptoms and maintaining overall well-being.
While Lenire represents a significant advancement in tinnitus management, further research is needed to ascertain its lasting effects and optimal use. Nonetheless, for many, it offers a beacon of hope in navigating the challenges posed by this debilitating condition.